Dimensional Fund Advisors’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.09M Sell
2,736,419
-443,434
-14% -$501K ﹤0.01% 2644
2025
Q1
$4.64M Sell
3,179,853
-381,773
-11% -$558K ﹤0.01% 2515
2024
Q4
$7.59M Buy
3,561,626
+831,146
+30% +$1.77M ﹤0.01% 2409
2024
Q3
$7.65M Buy
2,730,480
+179,840
+7% +$504K ﹤0.01% 2391
2024
Q2
$5.94M Buy
2,550,640
+507,021
+25% +$1.18M ﹤0.01% 2435
2024
Q1
$9.13M Buy
2,043,619
+508,374
+33% +$2.27M ﹤0.01% 2344
2023
Q4
$4.93M Sell
1,535,245
-303,111
-16% -$973K ﹤0.01% 2563
2023
Q3
$5.83M Buy
1,838,356
+546,215
+42% +$1.73M ﹤0.01% 2484
2023
Q2
$6.42M Sell
1,292,141
-757,115
-37% -$3.76M ﹤0.01% 2442
2023
Q1
$10.1M Sell
2,049,256
-340,848
-14% -$1.68M ﹤0.01% 2227
2022
Q4
$15K Buy
2,390,104
+655,317
+38% +$4.12K ﹤0.01% 2002
2022
Q3
$18.7M Buy
1,734,787
+480,099
+38% +$5.18M 0.01% 1872
2022
Q2
$14.3M Buy
1,254,688
+448,701
+56% +$5.12M 0.01% 2037
2022
Q1
$7.34M Buy
805,987
+61,259
+8% +$558K ﹤0.01% 2414
2021
Q4
$11.1M Buy
744,728
+403,573
+118% +$6.02M ﹤0.01% 2269
2021
Q3
$8.77M Buy
341,155
+319,311
+1,462% +$8.21M ﹤0.01% 2387
2021
Q2
$570K Hold
21,844
﹤0.01% 3138
2021
Q1
$771K Sell
21,844
-23,509
-52% -$830K ﹤0.01% 3058
2020
Q4
$1.15M Sell
45,353
-3,195
-7% -$80.7K ﹤0.01% 2952
2020
Q3
$1.83M Buy
+48,548
New +$1.83M ﹤0.01% 2768
2020
Q1
Sell
-18,373
Closed -$477K 3375
2019
Q4
$477K Sell
18,373
-576
-3% -$15K ﹤0.01% 3140
2019
Q3
$516K Buy
+18,949
New +$516K ﹤0.01% 3131